Valuation DexCom, Inc.

Stocks

Market Closed - Nasdaq 04:00:00 02/10/2026 HKT			5-day change	1st Jan Change
86.23 ^USD	-0.07%		-1.42%	+29.92%

10-01	RBC Raises Price Target on DexCom to $105 From $90, Keeps Outperform Rating	MT
09-28	Dexcom Publishes New Report During Easd 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	52,042	43,740	47,945	30,377	25,885	32,540	-	-
Change	-	-15.95%	9.61%	-36.64%	-14.79%	25.71%	-	-
Enterprise Value (EV) ¹	52,692	45,068	49,813	31,073	26,209	31,779	31,478	30,663
Change	-	-14.47%	10.53%	-37.62%	-15.65%	21.25%	-0.95%	-2.59%
P/E	346x	138x	95.5x	54.8x	31.8x	34.6x	29.2x	24.2x
PBR	23.1x	20.5x	23.1x	15.1x	9.3x	11.4x	9.54x	7.34x
PEG	-	1x	1.6x	5.94x	0.7x	1.8x	1.6x	1.2x
Capitalization / Revenue	21.3x	15x	13.2x	7.53x	5.55x	6.22x	5.61x	5.04x
EV / Revenue	21.5x	15.5x	13.8x	7.7x	5.62x	6.08x	5.43x	4.75x
EV / EBITDA	111x	60x	49.1x	28.1x	19.4x	19.1x	16.4x	13.8x
EV / EBIT	142x	92.9x	69.3x	41x	27x	25.5x	21.8x	17.8x
EV / FCF	989x	148x	97.3x	49.3x	24.3x	31.1x	25.8x	20.9x
FCF Yield	0.1%	0.68%	1.03%	2.03%	4.11%	3.21%	3.88%	4.79%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	0.3875	0.82	1.3	1.42	2.09	2.489	2.952	3.562
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	2,448	2,910	3,622	4,033	4,662	5,230	5,800	6,461
EBITDA ¹	472.7	751.6	1,014	1,105	1,349	1,667	1,921	2,218
EBIT ¹	370.7	485.1	718.6	757.1	969.3	1,248	1,446	1,719
Net income ¹	154.7	341.2	541.5	576.2	836.3	974.4	1,149	1,409
Net Debt ¹	650.1	1,328	1,868	695.9	323.2	-761.1	-1,061	-1,877
Reference price ²	134.24	113.24	124.09	77.77	66.37	86.23	86.23	86.23
Nbr of stocks (in thousands)	387,688	386,258	386,374	390,595	390,016	377,361	-	-
Announcement Date	10/2/22	9/2/23	8/2/24	13/2/25	12/2/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
DEXCOM, INC.	34.65x	6.08x	19.07x	-.--%	32.54B
ABBOTT LABORATORIES	27.39x	3.81x	14.72x	2.66%	167B
MEDTRONIC PLC	18.26x	3.37x	12.05x	3.26%	111B
STRYKER CORPORATION	21.23x	4.18x	14.6x	1.32%	105B
ESSILORLUXOTTICA	25.57x	2.51x	10.15x	2.82%	74.82B
CENCORA, INC.	16.96x	0.2x	12.44x	0.77%	59.11B
HOYA CORPORATION	29.74x	7.35x	19.01x	1.35%	51.8B
BECTON, DICKINSON AND COMPANY	34.32x	3.34x	11.44x	2.2%	48.5B
IDEXX LABORATORIES, INC.	35.06x	8.71x	24.52x	-.--%	40.79B
ALCON INC.	36.9x	3.01x	11.25x	0.58%	30.76B
Average	28.01x	4.26x	14.92x	1.5%	72.09B
Weighted average by Cap.	25.85x	3.93x	14.32x	1.93%